2659297
SCDGP · Clinical drug group packinfluenza A virus A/Bolivia/559/2013 (H1N1) antigen / influenza A virus A/New Caledonia/71/2014 (H3N2) antigen / influenza B virus B/Brisbane/60/2008 antigen / influenza B virus B/Phuket/3073/2013 antigen Nasal Product
Concept
Cross-maps
Synonyms
No additional synonyms recorded.
Related concepts
Common questions
What is the RxNorm code for influenza A virus A/Bolivia/559/2013 (H1N1) antigen / influenza A virus A/New Caledonia/71/2014 (H3N2) antigen / influenza B virus B/Brisbane/60/2008 antigen / influenza B virus B/Phuket/3073/2013 antigen Nasal Product?
influenza A virus A/Bolivia/559/2013 (H1N1) antigen / influenza A virus A/New Caledonia/71/2014 (H3N2) antigen / influenza B virus B/Brisbane/60/2008 antigen / influenza B virus B/Phuket/3073/2013 antigen Nasal Product is coded as 2659297 in RxNorm.
What is RxNorm code 2659297?
2659297 is the RxNorm identifier for influenza A virus A/Bolivia/559/2013 (H1N1) antigen / influenza A virus A/New Caledonia/71/2014 (H3N2) antigen / influenza B virus B/Brisbane/60/2008 antigen / influenza B virus B/Phuket/3073/2013 antigen Nasal Product. It is included in the current monthly NLM RxNorm release.
What term type is RxCUI 2659297?
2659297 is a SCDGP (Clinical drug group pack) in RxNorm.
What is the UMLS mapping for 2659297?
2659297 maps to UMLS C5843106.